Bank Of Nova Scotia Charles River Laboratories International, Inc. Transaction History
Bank Of Nova Scotia
- $47.4 Billion
- Q3 2024
A detailed history of Bank Of Nova Scotia transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bank Of Nova Scotia holds 4,779 shares of CRL stock, worth $803,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,779
Previous 3,035
57.46%
Holding current value
$803,923
Previous $626,000
50.32%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
691Shares Held
52MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$856 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$629 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$358 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$326 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...